Hodgkin’s lymphoma, lymphocytic-histiocytic predominance

The information provided on this page is for informational purposes only. The National Organization for Rare Disorders (NORD) does not endorse the information presented. The content has been gathered in partnership with the MONDO Disease Ontology. Please consult with a healthcare professional for medical advice and treatment.

Print

Disease Overview

A subtype of classical Hodgkin lymphoma with scattered Hodgkin and Reed-Sternberg cells and a nodular or less often diffuse cellular background consisting of small lymphocytes and with an absence of neutrophils and eosinophils. (WHO, 2008)


Synonyms

  • Hodgkin lymphoma, lymphocyte-rich
  • Hodgkin lymphoma, lymphocytic-histiocytic predominance
  • Hodgkin's disease, lymphocyte predominance
  • Hodgkin's disease, lymphocyte predominance [obs]
  • LRCHL
  • classic Hodgkin lymphoma, lymphocyte-rich type
  • lymphocyte rich Hodgkin lymphoma
  • lymphocyte rich Hodgkin's disease
  • lymphocyte rich Hodgkin's lymphoma
  • lymphocyte rich classical Hodgkin lymphoma
  • lymphocyte rich classical Hodgkin's disease
  • lymphocyte rich classical Hodgkin's lymphoma
  • lymphocyte-rich Classic Hodgkin lymphoma
  • lymphocyte-rich classical Hodgkin lymphoma
  • lymphocyte-rich classical Hodgkin's lymphoma

GARD Disease Summary

The Genetic and Rare Diseases Information Center (GARD) has information and resources for patients, caregivers, and families that may be helpful before and after diagnosis of this condition. GARD is a program of the National Center for Advancing Translational Sciences (NCATS), part of the National Institutes of Health (NIH).

View report
Orphanet

Orphanet has a summary about this condition that may include information on the diagnosis, care, and treatment as well as other resources. Some of the information and resources are available in languages other than English. The summary may include medical terms, so we encourage you to share and discuss this information with your doctor. Orphanet is the French National Institute for Health and Medical Research and the Health Programme of the European Union.

View report